Clincosm LogoSign in Get a demo

Major Depressive Disorder

Showing NaN - NaN of 155
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDD Trial in Canada, United States (PNB01 fixed dose combination of pipamperone and citalopram, Citalopram, Pipamperone)

Completed
Has Results
  • Major Depressive Disorder
  • PNB01 fixed dose combination of pipamperone and citalopram
  • +2 more
  • Glendale, California
  • +30 more
Mar 14, 2022

Treatment Resistant Depression, Electroconvulsive Therapy, ECT Trial in United States (electroconvulsive therapy (ECT),

Recruiting
  • Treatment Resistant Depression
  • +8 more
  • New Haven, Connecticut
  • +4 more
Mar 11, 2022

MDD Trial in United States (BTRX-335140, Placebo)

Active, not recruiting
  • Major Depressive Disorder
  • Phoenix, Arizona
  • +37 more
Mar 11, 2022

MDD Trial in United States (Levomilnacipran ER, Fluoxetine, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • Levomilnacipran ER
  • +2 more
  • Little Rock, Arkansas
  • +50 more
Mar 1, 2022

MDD, Breast Cancer, Venlafaxine Trial in New York (Interpersonal Psychotherapy, Venlafaxine HCl ER)

Recruiting
  • Major Depressive Disorder
  • +2 more
  • Interpersonal Psychotherapy
  • Venlafaxine HCl ER
  • New York, New York
    Herbert Irving Comprehensive Cancer Center, Columbia University
Mar 7, 2022

MDD Trial in New York (Active Biofeedback, Sham Biofeedback)

Recruiting
  • Major Depressive Disorder
  • Active Biofeedback
  • Sham Biofeedback
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Mar 15, 2022

Bipolar Depression, MDD Trial in Worldwide (Lumateperone, Placebos)

Recruiting
  • Bipolar Depression
  • Major Depressive Disorder
  • Garden Grove, California
  • +41 more
Feb 28, 2022

MDD Trial in New York (Brain stimulation)

Recruiting
  • Major Depressive Disorder
  • Brain stimulation
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Feb 4, 2022

MDD, Dysthymia, Depression Trial in New York (L-DOPA, Placebo Oral Tablet)

Suspended
  • Major Depressive Disorder
  • +2 more
  • New York, New York
    New York State Psychiatric Institute
Jan 26, 2022

MDD Trial in Atlanta, New York, Dallas (ALTO-300 PO Tablet)

Recruiting
  • Major Depressive Disorder
  • ALTO-300 PO Tablet
  • Atlanta, Georgia
  • +2 more
Feb 3, 2022

MDD Trial in New York (Ixekizumab, Placebo)

Recruiting
  • Major Depressive Disorder
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Nov 16, 2021

MDD Trial in United States (SAGE-217, Placebo)

Terminated
  • Major Depressive Disorder
  • Bentonville, Arkansas
  • +45 more
Oct 15, 2021

MDD, Treatment Resistant Depression Trial in New York (Medtronic Summit RC+S DBS system)

Recruiting
  • Major Depressive Disorder
  • Treatment Resistant Depression
  • Medtronic Summit RC+S DBS system
  • New York, New York
    Icahn School of Medicine at Mount Sinai, Mount Sinai West
Sep 23, 2021

Depressive Disorder, Depression, Depressive Disorder, Major Trial in United States (Synchronized Transcranial Magnetic

Completed
Has Results
  • Depressive Disorder
  • +4 more
  • Synchronized Transcranial Magnetic Stimulation (sTMS)
  • Sham Stimulation
  • La Jolla, California
  • +13 more
Aug 9, 2021

MDD, Treatment Resistant Depression Trial in New York (AXS-05, Bupropion SR)

Enrolling by invitation
  • Major Depressive Disorder
  • Treatment Resistant Depression
  • New York, New York
    Axsome Research Site
Jul 20, 2021

MDD Trial in Worldwide (SPD489 (Lisdexamfetamine dimesylate) + Antidepressant)

Terminated
Has Results
  • Major Depressive Disorder
  • SPD489 (Lisdexamfetamine dimesylate) + Antidepressant
  • Birmingham, Alabama
  • +211 more
Jun 9, 2021

MDD Trial in Worldwide (Antidepressant + SPD489 (Lisdexamfetamine dimesylate) 10 mg, Antidepressant + SPD489 (Lisdexamfetamine

Completed
Has Results
  • Major Depressive Disorder
  • Antidepressant + SPD489 (Lisdexamfetamine dimesylate) 10 mg
  • +4 more
  • Little Rock, Arkansas
  • +81 more
May 25, 2021

MDD, Bipolar Disorder Trial in New York (behavioral, device, drug)

Completed
Has Results
  • Major Depressive Disorder
  • Bipolar Disorder
  • Wake Therapy
  • +2 more
  • New York, New York
  • +1 more
Feb 24, 2021

MDD Trial in New York (Fisher Wallace Cranial Electrotherapy Stimulator Device)

Active, not recruiting
  • Major Depressive Disorder
  • Fisher Wallace Cranial Electrotherapy Stimulator Device
  • New York, New York
    ProofPilot (Remote Virtual Trial)
Feb 9, 2021

MDD, Dysthymic Disorder, Depressive Disorder, NOS Trial in New York (Antidepressant Medication)

Completed
Has Results
  • Major Depressive Disorder
  • +2 more
  • Antidepressant Medication
  • New York, New York
    New York State Psychiatric Institute
Jan 12, 2021

MDD Trial in New York (Ketamine)

Terminated
  • Major Depressive Disorder
  • New York, New York
    New York State Psychiatric Institute
Jan 20, 2021

MDD Trial in United States (Vortioxetine, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • Phoenix, Arizona
  • +78 more
Dec 16, 2020

MDD Trial in Puerto Rico, United States (AGO178)

Terminated
  • Major Depressive Disorder
  • Birmingham, Alabama
  • +97 more
Dec 16, 2020

MDD Trial in Puerto Rico, United States (Agomelatine (AGO178C), Placebo)

Completed
  • Major Depressive Disorder
  • Agomelatine (AGO178C)
  • Placebo
  • Birmingham, Alabama
  • +44 more
Dec 16, 2020

MDD Trial in Puerto Rico, United States (agomelatine, )

Completed
  • Major Depressive Disorder
  • Scottsdale, Arizona
  • +43 more
Dec 15, 2020